We bring you the latest news from the healthcare about the health care in the United Kingdom.

vrijdag 14 september 2018

Oncogene - Table of Contents alert Volume 37 Issue 37

If you are unable to see the message below, click here to view.

CRISPR: Predict Cas9 and sgRNA binding with accuracy

Diagenode's iDeal ChIP-seq Kit for Transcription Factors:
  • Latest method of choice to verify sgRNA specificity
  • Uses robust ChIP method followed by qPCR to verify enrichment of dCas9 at expected target
  • Sequencing analysis of the immunoprecipitated DNA shows off-target effects genome-wide
Learn more and read the new application note.

Volume 37, Issue 37

In this issue
Brief Communications
Also new
Register for the latest nature.com webcast

Distinct Metabolic Profiling of Invading PANC-1 Pancreatic Cancer Cells
During this webcast Dr. Mayumi Fujita of the National Institutes for Quantum and Radiological Science and Technology in Japan will address the method of real-time imaging of invading cancer cells and describe how this model could be useful for other studies. 

Register for FREE today 

Sponsored by IncuCyte


Estrogen receptor β promotes renal cell carcinoma progression via regulating LncRNA HOTAIR-miR-138/200c/204/217 associated CeRNA network

Jie Ding, Chiuan-Ren Yeh, Yin Sun, Changyi Lin, Joshua Chou et al.

Oncogene 2018 37 :5037 - 5053; May 23, 2018; 10.1038/s41388-018-0175-6


Abstract | Full Text

Helicobacter pylori pathogen regulates p14ARF tumor suppressor and autophagy in gastric epithelial cells

Andela Horvat, Jennifer M. Noto, Balamurugan Ramatchandirin, Elena Zaika, Manikandan Palrasu et al.

Oncogene 2018 37 :5054 - 5065; May 30, 2018; 10.1038/s41388-018-0343-8


Abstract | Full Text

PDLIM7 and CDH18 regulate the turnover of MDM2 during CDK4/6 inhibitor therapy-induced senescence

Mary E. Klein, Mark A. Dickson, Cristina Antonescu, Li-Xuan Qin, Scott J. Dooley et al.

Oncogene 2018 37 :5066 - 5078; May 23, 2018; 10.1038/s41388-018-0332-y


Abstract | Full Text

Artemisitene suppresses tumorigenesis by inducing DNA damage through deregulating c-Myc-topoisomerase pathway

Jian Chen, Wenjuan Li, Ke Cui, Kaiyuan Ji, Shuxiang Xu et al.

Oncogene 2018 37 :5079 - 5087; May 24, 2018; 10.1038/s41388-018-0331-z


Abstract | Full Text

Myeloid-restricted ablation of Shp2 restrains melanoma growth by amplifying the reciprocal promotion of CXCL9 and IFN-γ production in tumor microenvironment

P. Xiao, Y. Guo, H. Zhang, X. Zhang, H. Cheng et al.

Oncogene 2018 37 :5088 - 5100; May 24, 2018; 10.1038/s41388-018-0337-6


Abstract | Full Text

RANK-c attenuates aggressive properties of ER-negative breast cancer by inhibiting NF-κB activation and EGFR signaling

Chaido Sirinian, Anastasios D. Papanastasiou, Michail Schizas, Magda Spella, Georgios T. Stathopoulos et al.

Oncogene 2018 37 :5101 - 5114; May 29, 2018; 10.1038/s41388-018-0324-y


Abstract | Full Text

Melanoma protective antitumor immunity activated by catalytic DNA

Hong Cai, Eun-Ae Cho, Yue Li, Jim Sockler, Christopher R. Parish et al.

Oncogene 2018 37 :5115 - 5126; May 29, 2018; 10.1038/s41388-018-0306-0


Abstract | Full Text

Brief Communications

Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer

Sara Al Habyan, Christina Kalos, Joseph Szymborski & Luke McCaffrey

Oncogene 2018 37 :5127 - 5135; May 23, 2018; 10.1038/s41388-018-0317-x


Abstract | Full Text

Shared and independent functions of aPKCλ and Par3 in skin tumorigenesis

Susanne Vorhagen, Dominik Kleefisch, Oana-Diana Persa, Annika Graband, Alexandra Schwickert et al.

Oncogene 2018 37 :5136 - 5146; May 23, 2018; 10.1038/s41388-018-0313-1


Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

Nature is part of Springer Nature. © 2018 Springer Nature Limited. All rights reserved.

Springer Nature